跳至主要内容
临床试验/NCT04445506
NCT04445506已完成不适用

The Effect of the Short-term Use of Systemic Corticosteroids in COVID-19 Patients in Regard to Hospital Length of Stay, Morbidly and/or Mortality.

The Miriam Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Effect on transfers to ICU and escalation of care needing mechanical ventilation

研究概览

简要总结

The investigators reviewed the charts of SARS-CoV-2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate disease with at least a 30% increase in CRP within 36 hours of admission, and with increasing oxygen requirements.
  • All patients with severe disease with evidence of escalating oxygen requirements
  • The presence of secondary bacterial infections as a probable cause of increasing CRP levels was excluded in all selected patients.
  • Pulmonary embolism and /or cardiac dysfunction were excluded as probable causes of worsening hypoxia in all selected patients.

排除标准

  • All patients on other treatment modalities- Remdesivir and/or Convalescent plasma who showed evidence of clinical improvement as per decrease in CRP levels and/or oxygen requirements were excluded.
  • Patient with associated COPD exacerbation who would benefit from the use of steroids.
  • Patients with Diabetic ketoacidosis, hyperglycemic hyperosmolar state, active concurrent bacterial infections.
  • Patients with history of steroid-induced mania and/or psychosis.

研究组 & 干预措施

SARS-CoV2 patients that received dexamethasone

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Effect on transfers to ICU and escalation of care needing mechanical ventilation

时间窗: 2 months

次要结局

  • Effect on length of stay(2 months)
  • Change in CRP levels(2 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验